Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2010 | 03-2009 | 03-2008 | |
| Cash Flows From Operating Activities | |||
| Accounts receivable | 2 | 43 | -71 |
| Other Working Capital | -8 | 23 | 75 |
| Other Operating Activity | -873 | -292 | -518 |
| Operating Cash Flow | $-879 | $-226 | $-514 |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -718 | -2,820 |
| Purchase Of Investment | -4,003 | -10,555 | N/A |
| Sale Of Investment | 24,826 | N/A | N/A |
| Investing Cash Flow | $20,823 | $-11,273 | $-2,820 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 1,032 | 3,910 | 21,304 |
| Financing Cash Flow | $1,032 | $3,910 | $21,304 |
| Beginning Cash Position | 33,149 | 38,228 | N/A |
| End Cash Position | 54,126 | 30,638 | 17,970 |
| Net Cash Flow | $20,977 | $-7,590 | $17,970 |
| Free Cash Flow | |||
| Operating Cash Flow | -879 | -226 | -514 |
| Capital Expenditure | N/A | -718 | -2,820 |
| Free Cash Flow | -879 | -944 | -3,334 |